|
TULP4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.620600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.750400E-01 |
| Normal-vs-Stage2 |
4.849200E-01 |
| Normal-vs-Stage3 |
8.439400E-01 |
| Normal-vs-Stage4 |
4.280200E-02 |
| Stage1-vs-Stage2 |
8.046200E-01 |
| Stage1-vs-Stage3 |
6.183400E-01 |
| Stage1-vs-Stage4 |
4.133200E-01 |
| Stage2-vs-Stage3 |
5.443000E-01 |
| Stage2-vs-Stage4 |
4.272600E-01 |
| Stage3-vs-Stage4 |
2.052000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.373000E-01 |
| Normal-vs-AfricanAmerican |
5.504400E-01 |
| Normal-vs-Asian |
1.790230E-01 |
| Caucasian-vs-AfricanAmerican |
2.891200E-01 |
| Caucasian-vs-Asian |
3.104400E-01 |
| AfricanAmerican-vs-Asian |
2.419400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.438000E-01 |
| Normal-vs-Female |
8.236400E-01 |
| Male-vs-Female |
6.444600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.929600E-01 |
| Normal-vs-Extreme_Weight |
2.666200E-02 |
| Normal-vs-Obese |
1.812220E-01 |
| Normal-vs-Extreme_Obese |
6.794200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.835600E-01 |
| Normal_Weight-vs-Obese |
9.233700E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.228000E-01 |
| Extreme_Weight-vs-Obese |
5.602000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
4.005000E-01 |
| Obese-vs-Extreme_Obese |
9.607000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.517600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.338000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.538780E-01 |
| Normal-vs-Age(81-100Yrs) |
6.374000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.924800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.799600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.859900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.243700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.917600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.018600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.929400E-01 |
| Normal-VS-Type2 PRCC |
1.105570E-01 |
| Normal-VS-KIRP CIMP |
2.994600E-01 |
| Normal-VS-Unclassified PRCC |
7.076200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.055600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.726800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.266400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.019420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.642200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.639200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.156400E-02 |
| Normal-vs-N1 |
8.317600E-01 |
| Normal-vs-N2 |
3.541300E-03 |
| N0-vs-N1 |
1.200230E-01 |
| N0-vs-N2 |
3.974400E-01 |
| N1-vs-N2 |
1.804000E-01 |
|
|
